OBERWEIS ASSET MANAGEMENT INC/

Position in CRMD — CorMedix Inc.

CIK 937886 LISLE, IL

Position in CRMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,223,470

-$1,140,017 QoQ

Shares Held

1,211,115

+50.4% QoQ

Ownership

1.54%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OBERWEIS ASSET MANAGEMENT INC/ holds $73,946,027 across 4 Biotechnology names. CRMD ranks #4 (11.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	1,365,941	$32,181,569
2	CPRX	Catalyst Pharmaceuticals, Inc.	780,570	$19,326,913
3	HALO	Halozyme Therapeutics, Inc.	219,930	$14,214,075
4	CRMD	CorMedix Inc. This page	1,211,115	$8,223,470

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,223,470	1,211,115	+50.4%	Shares	Sole	2026-05-15
2025-12-31	$9,363,487	805,115	+2.5%	Shares	Sole	2026-02-17
2025-09-30	$9,137,691	785,700	+62.0%	Shares	Sole	2025-11-17
2025-06-30	$5,975,200	485,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,987,600	485,000	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.